Stock Events

Stock Events

Search...

Haemato

€21.4

2

-€0.4-1.83% Thursday 16:30

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

111.91M

P/E Ratio

11.57

Dividend Yield

0.19%

Dividend

0.04

Upcoming

Dividend Payment

Dividend Payment

Dividends

0.19%Dividend Yield

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

-66.72%

1Y Growth

-96.76%

Earnings

15MayExpected

Q4 2020

Q2 2021

Q4 2021

Q1 2023

Q2 2023

Q3 2023

Q1 2024

-0.83

-0.1

0.62

1.35

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HAEK.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Haemato in the development and marketing of medical products.

Pfizer is a multinational pharmaceutical corporation that competes with Haemato in the pharmaceuticals market, particularly in the areas of research, development, and distribution of drugs.

Merck & Co., Inc. is a leading global biopharmaceutical company that competes with Haemato in the discovery, development, and commercialization of medicines and vaccines.

Johnson & Johnson

Johnson & Johnson is a comprehensive healthcare company that has a strong presence in the pharmaceuticals sector, making it a competitor to Haemato in various therapeutic areas.

GlaxoSmithKline is a global healthcare company that engages in the creation and distribution of pharmaceuticals, vaccines, and consumer healthcare products, competing with Haemato.

AbbVie is a biopharmaceutical company that develops and markets therapies, directly competing with Haemato in the pharmaceuticals and healthcare market.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines, competing with Haemato in several therapeutic areas.

Sanofi is a global life sciences company that offers a wide range of pharmaceutical products, directly competing with Haemato in the healthcare and pharmaceutical sectors.

Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics, and competes with Haemato in the development and marketing of medical solutions.

AstraZeneca is a global, science-led biopharmaceutical business that competes with Haemato in the discovery and development of prescription medicines.

About

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.

Show more...

CEO

Mr. Patrick Brenske

Employees

76

Country

DE

ISIN

DE000A289VV1

WKN

000A289VV

Listings